These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12713619)

  • 21. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
    Hisaoka M; Okamoto S; Morimitsu Y; Tsuji S; Hashimoto H
    Virchows Arch; 1998 Oct; 433(4):323-9. PubMed ID: 9808434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias.
    Wojcik I; Szybka M; Golanska E; Rieske P; Blonski JZ; Robak T; Bartkowiak J
    Neoplasma; 2005; 52(4):318-24. PubMed ID: 16059649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MDM2 amplification and loss of heterozygosity at Rb and p53 genes: no simultaneous alterations in the oncogenesis of liposarcomas.
    Schneider-Stock R; Walter H; Radig K; Rys J; Bosse A; Kuhnen C; Hoang-Vu C; Roessner A
    J Cancer Res Clin Oncol; 1998; 124(10):532-40. PubMed ID: 9829856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma.
    Shibagaki I; Tanaka H; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
    Clin Cancer Res; 1995 Jul; 1(7):769-73. PubMed ID: 9816044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines.
    Taylor AC; Shu L; Danks MK; Poquette CA; Shetty S; Thayer MJ; Houghton PJ; Harris LC
    Med Pediatr Oncol; 2000 Aug; 35(2):96-103. PubMed ID: 10918230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 gene mutations are uncommon but p53 is commonly expressed in anaplastic large-cell lymphoma.
    Rassidakis GZ; Thomaides A; Wang S; Jiang Y; Fourtouna A; Lai R; Medeiros LJ
    Leukemia; 2005 Sep; 19(9):1663-9. PubMed ID: 15990866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas.
    Patterson H; Gill S; Fisher C; Law MG; Jayatilake H; Fletcher CD; Thomas M; Grimer R; Gusterson BA; Cooper CS
    Br J Cancer; 1994 Jun; 69(6):1052-8. PubMed ID: 8198970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours.
    Yamamoto H; Yoshida A; Taguchi K; Kohashi K; Hatanaka Y; Yamashita A; Mori D; Oda Y
    Histopathology; 2016 Jul; 69(1):72-83. PubMed ID: 26647767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inflammatory myofibroblastic tumor].
    Leuschner I
    Pathologe; 2010 Mar; 31(2):106-8. PubMed ID: 20063099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma.
    Park HR; Jung WW; Bertoni F; Bacchini P; Park JH; Kim YW; Park YK
    Pathol Res Pract; 2004; 200(6):439-45. PubMed ID: 15310147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors.
    Hussong JW; Brown M; Perkins SL; Dehner LP; Coffin CM
    Mod Pathol; 1999 Mar; 12(3):279-86. PubMed ID: 10102613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal expression of MDM2 in prostate carcinoma.
    Leite KR; Franco MF; Srougi M; Nesrallah LJ; Nesrallah A; Bevilacqua RG; Darini E; Carvalho CM; Meirelles MI; Santana I; Camara-Lopes LH
    Mod Pathol; 2001 May; 14(5):428-36. PubMed ID: 11353053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation.
    Higashiyama M; Doi O; Kodama K; Yokouchi H; Kasugai T; Ishiguro S; Takami K; Nakayama T; Nishisho I
    Br J Cancer; 1997; 75(9):1302-8. PubMed ID: 9155050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myofibroblastic tumours: neoplasias with divergent behaviour. Ultrastructural and flow cytometric analysis.
    Biselli R; Boldrini R; Ferlini C; Boglino C; Inserra A; Bosman C
    Pathol Res Pract; 1999; 195(9):619-32. PubMed ID: 10507082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival.
    Bahnassy AA; Zekri AR; Abdallah S; El-Shehaby AM; Sherif GM
    Pathol Int; 2005 Feb; 55(2):53-62. PubMed ID: 15693850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New insights into p53 protein stabilisation in oral squamous cell carcinoma.
    Partridge M; Kiguwa S; Emilion G; Pateromichelakis S; A'Hern R; Langdon JD
    Oral Oncol; 1999 Jan; 35(1):45-55. PubMed ID: 10211310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The expression of Mdm2 protein and p53 mutation in lung squamous cell carcinomas and their clinicopathological significance].
    Zhang J; Liu H; Li S; Gu C
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Mar; 22(3):163-5. PubMed ID: 11812371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MDM2 amplification, P53 mutation, and accumulation of the P53 gene product in malignant fibrous histiocytoma.
    Reid AH; Tsai MM; Venzon DJ; Wright CF; Lack EE; O'Leary TJ
    Diagn Mol Pathol; 1996 Mar; 5(1):65-73. PubMed ID: 8919547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MDM2 gene amplification and lack of p53 point mutations in Hodgkin and Reed-Sternberg cells: results from single-cell polymerase chain reaction and molecular cytogenetic studies.
    Küpper M; Joos S; von Bonin F; Daus H; Pfreundschuh M; Lichter P; Trümper L
    Br J Haematol; 2001 Mar; 112(3):768-75. PubMed ID: 11260082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.